SPOTLIGHT -
FDA Launches Major Push for New Antimicrobials
The regulator teams with other health agencies on strategies to combat antibiotic resistance, reshape R&D incentive schemes.
Big Companies FDA Fast Lanes Appendix
Does being an orphan speed up FDA approval?
Targeting the Affluent Fig2
Targeting the Affluent Fig1
Targeting the Affluent Fig5
Targeting the Affluent Fig3
Targeting the Affluent Fig4
CPhI Worldwide Announces Finalists of Largest Ever Pharma Awards
2018 CPhI Pharma Awards Finalists Announced
How DSCSA Changes the Licensing Landscape
A look at the Drug SUpply Chain Security Act and how it impacts serialization and third-party logistics licensing.
UK Research Partners Secure £1M Innovation Boost for Novel Deep Learning Drug Discovery Platform
CPhI Annual Report Part 2
CPhI Annual Report Looks at Next 5 years
Oncology Tool Provides Weekly Performance and Market Share Analytics
Clinical Data Management: Patients’ Lives are on the Line
UK's Amryt to Open US Clinical Trial Sites for Epidermolysis Bullosa
Hospitals Back Generic Drug Production Venture
CEOS see Quick ROI on Digital Transformation and AI Investments
Hu-manity.co and IBM Partner for Personal Data Property Rights
Aetion Partners with Brigham and Women's Hospital and Harvard Medical School
HBA and Healthcare Companies Partner in Gender Parity Collaborative
FDA Supports More Focused Development of Targeted Pain Therapies
To help combat the nation’s opioid epidemic, FDA is promoting a more tailored approach to developing and testing effective analgesics, with the aim of bringing less addictive pain treatments to market more quickly.
Country Report: UK
Faced with looming uncertainties triggered by the upcoming Brexit, the United Kingdom’s life sciences sector, which constitutes one of the last big remaining bastions of British industry, is not about to rest on its laurels.
Pharmaceutical Executive, September 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive September 2018 issue in an interactive PDF format.
MassBio Releases 2018 Industry Snapshot
Yescarta Receives European Marketing Authorization for Treatment of Relapsed or Refractory DLBCL and PMBC
Pharm Exec’s 14th Annual Press Audit: The Opioid Crisis Takes Center Stage
The opioid crisis dominated the news in this year’s annual audit of press coverage of the pharmaceutical industry. George P. Sillup and Stephen J. Porth report.
3 Tips for Successful Public-Private Partnerships in Healthcare
A list of three key elements when looking at public-private partnerships to tackle public health challenges.
Middle East and Africa Pharma Economy to Reach $38.8 BN by 2021
